ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Gain valuable knowledge on improving treatment decisions, identifying key biomarkers, and managing adverse events in the evolving landscape of gastric cancer care.”
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Gain valuable knowledge on improving treatment decisions, identifying key biomarkers, and managing adverse events in the evolving landscape of gastric cancer care.”